Doctoral thesis.

Presentation of the Doctoral Thesis by Marta Pascual Gilabert, featuring the results of all research related to the development of MyoDM, from the Discovery phase to the clinical study and its outcomes. Titled “Nutritional management of Myotonic Dystrophy Type 1”.
DOCTORAL THESIS PhD Marta Pascual Gilabert* “Nutritional management of Myotonic Dystrophy Type 1” (2022 NIUB). Thesis directors: PhD Josep Castells Boliart* & PhD David Miguel Centeno*.

Highest qualification awarded by the Thesis Committee: Dr. Rafael Mañez Mendiluce**, Dr. Carmen Escolano Mirón***, Arturo López Castel****

MyoDM, a breakthrough in the treatment of Steinert's Myotonic Dystrophy. Research and innovation at the service of your well-being.

¿Do you have any questions
or need more information?

Fill out the form and our team will respond as soon as possible.

Related news.

Scientific article with a complete overview through 2022 of the most recent drug development programs undergoing preclinical and clinical evaluation.

View report

Scientific article compiling the most recent drug development projects currently in the preclinical and clinical phases

View report

Myogem’s MyoDM clinical study successfully completes patient recruitment. Post on LinkedIn

At the end of February 2021, the patient recruitment phase of the clinical study NCT04634682 by Myogem concluded. The study...